Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Valsartan NDMA Lawsuits Cleared To Move Forward, After Motion for Reconsideration Rejected A federal judge ruled that, unlike in Zantac claims, Valsartan NDMA lawsuits do not require proof the drug turns into NDMA in the body, because high levels of the cancer-causing chemical were already present in the pills. December 29, 2022 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all valsartan NDMA lawsuits has rejected a renewed effort by manufacturers of the recalled blood pressure drug to have plaintiffs’ expert witnesses excluded, finding that a recent order dismissing thousands of Zantac lawsuits involving the same cancer-causing contaminant has no impact the Court’s prior decision to allow the valsartan claims to move forward. The litigation stems from a series of valsartan recalls issued in late 2018, after it was discovered that changes to the generic drug manufacturing process caused pills to be distributed for years with high levels of N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA) and other chemical byproducts, which are known to increase the risk of stomach cancer, liver cancer, esophageal cancer, prostate cancer, pancreatic cancer, and other injuries. More than 1,100 valsartan lawsuits have already been filed against manufacturers and distributors of the contaminated pills, and the parties are preparing a small group of representative cases for early “bellwether” trials, which are designed to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout hundreds of claims. VALSARTAN LAWSUITS Were you prescribed contaminated Valsartan drugs? Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION VALSARTAN LAWSUITS Were you prescribed contaminated Valsartan drugs? Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints filed in U.S. District Courts nationwide, all valsartan NDMA lawsuits have been centralized for pretrial proceedings before U.S. District Judge Robert B. Kugler in the District of New Jersey, as part of a multidistrict litigation (MDL). Earlier this year, Judge Kugler issued an order rejecting a motion filed by the drug makers to exclude plaintiffs expert witnesses that will be used to establish a link between valsartan and cancer, finding that the opinions were based on sound scientific findings and sufficiently reliable for the cases to go before a jury. However, following a recent ruling in a different federal MDL, the drug makers filed notice of a motion for reconsideration (PDF) on December 20, asking the Court to reverse it’s earlier ruling or allow an immediate appeal before valsartan trials get underway. Federal Zantac Lawsuits Dismissed More than a year after the valsartan recalls raised concerns about NDMA in drugs, testing found that the popular heartburn drug Zantac (ranitidine) contained dangerously high levels of the cancer-causing chemical. However, unlike valsartan, where the NDMA resulted from changes in the manufacturing process and was present before the pills were ingested, testing found that the active pharmaceutical ingredient in Zantac may convert to NDMA once the pills are inside the body. More than 100,000 Zantac NDMA lawsuits were brought throughout the federal court system, raising similar allegations to those presented in the valsartan litigation, indicating that former users developed bladder cancer, esophageal cancer, liver cancer, pancreatic cancer, stomach cancer or other injuries as the pills moved through the digestive system. On December 6, U.S. District Judge Robin L. Rosenberg in the Southern District of Florida, who has been presiding over coordinated Zantac MDL proceedings over the past two and a half years, issued a controversial ruling that excluded plaintiffs’ expert witnesses from testifying. Judge Rosenberg determined that plaintiffs’ expert evidence failed to establish that enough ranitidine transformed into NDMA to be a viable cancer threat, resulting in the dismissal of all Zantac claims. Defendants Sought Reconsideration of Valsartan NDMA Expert Ruling Shortly after the Zantac ruling, defendants involved in the valsartan litigation filed asked Judge Kugler to reconsider his prior ruling, arguing that the opinion issued by Judge Rosenberg highlights “fundamental flaws” in the theory that trace amounts of NDMA causes cancer in humans. In the alternative, the drug makers and distributors asked the Court to certify the prior valsartan NDMA decision for interlocutory appeal, so that an immediate review of the decision could be obtained before more than 1,000 claims proceed to trial. Only two days after the motion for reconsideration was filed, Judge Kugler issued an order (PDF) on December 22, rejecting the motion and clearing the valsartan NDMA lawsuits to continue moving forward. Judge Kugler pointed out that while in the Zantac cases, plaintiffs alleged that ranitidine transformed into NDMA due to the body’s natural processes, valsartan is known to have had the high amounts of NDMA in it before it was ingested, leaving no question about the amounts plaintiffs took into their bodies when they consumed a valsartan pill. Judge Kugler noted that there is “no scientific doubt about the presence of nitrosamines in the human body upon ingestion of the ‘valsartan-containing drugs containing NDMA or NDEA’ (VCDs) because the VCDs contained nitrosamine before ingestion” before declaring there was not sufficient reason to reconsider earlier rulings on the admissibility of plaintiffs’ expert witnesses in the Valsartan litigation. He also denied a request to certify for interlocutory appeal, which defendants also sought. The ruling means that while Zantac litigation in federal court has potentially ended if plaintiffs fail to successfully appeal Judge Rosenberg’s ruling, the valsartan lawsuits will continue to proceed to trial. January 2023 Valsartan Lawsuit Update As of late December 2022, there are at least 1,174 valsartan lawsuits pending in the federal MDL. However, the size and scope of the litigation is expected to continue to increase throughout 2023, as former users of the recalled blood pressure drug continue to be diagnosed with cancer caused by NDMA in valsartan. In 2023, the parties are expected to continue preparing a small group of representative “bellwether” valsartan lawsuits for early trial dates, which will be closely watched to determine the respective strengths and weaknesses of claims and the average amounts of any valsartan lawsuit payouts awarded. Judge Kugler previously appointed retired U.S. District Judges Gregory M. Sleet and Lawrence F. Stengel as a special master to help the parties negotiation potential valsartan settlements, which may help avoid the need for hundreds of individual claims to go before juries. If the parties fail to make progress toward a resolution for the litigation or establish a valsartan cancer settlements program, it is expected that Judge Kugler will move forward with a series of “bellwether” trials, and then consider remanding large numbers of claims back to U.S. District Courts nationwide for separate trial dates in the future. Do You Qualify for a Valsartan Settlement? Lawyers provide free consultations and claim evaluations for former users of valsartan diagnosed with cancer. Settlement benefits may be available CONTACT A LAWYER Tags: Cancer, Drug Recall, Hypertension, NDMA, Valsartan, Zantac More Valsartan Lawsuit Stories Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases May 28, 2025 Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named March 27, 2025 Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named March 27, 2025
Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)